Gastric inflammation is an invariable finding in patients infected with H. pylori and represents the host immune response to the organism 1 .
Histologically, H. pylori-associated chronic gastritis is characterised by surface epithelial degeneration, infiltration of the mucosa by chronic inflammatory cells (lymphocytes, plasma cells, and occasional eosinophils), and a characteristic but variable 'active' component consisting of neutrophils 2 . Qualitative or quantitative differences in H. pylori-induced gastric mucosal inflammation may play a pivotal role in determining the varied clinical outcomes of infection. This review focuses on the interactions between the organism and host cells which lead to mucosal inflammation. 
Mechanisms of inflammation in H. pylori infection
When considering the mechanisms of H. pylori-induced mucosal inflammation, it is useful to consider the potential routes by which the organism may interact with host cells to initiate both direct cell injury and an immune response. H. pylori colonises the human gastric epithelium, living within the mucus layer in close proximity with the epithelial surface (to which it may adhere), but without invading the mucosa. There are two main mechanisms by which H. pylori (or its products) may produce gastric inflammation. Firstly, the organism may interact with surface epithelial cells, producing either direct cell damage or the liberation of epithelial-derived pro-inflammatory mediators (chemokines). Secondly, H. pylori-derived products may gain access to the underlying mucosa, thereby directly stimulating host non-specific and specific immune responses involving the liberation of a variety of cytokine messengers (Fig. 1 , Table 1 ).
Direct mucosal injury
There are a variety of ways in which H. pylori may directly damage the surface epithelial layer 3 , thereby contributing to changes in mucosal permeability and enhanced antigen exposure 4 . Adherence of the organism to gastric epithelial cells is well recognised and is accompanied by loss of microvilli, irregularity of the luminal border, and intracellular changes including loss of cytoplasm, oedema and vacuolation 5 . Surface epithelial degeneration correlates with the numbers of H. pylori in close contact with the epithelial plasma membrane, a finding that supports a direct toxic effect of bacterial products on epithelial cells 6 . Approximately 50% of H. pylori strains produce a heat-labile, proteasesensitive vacuolating cytotoxin which induces vacuole formation in cultured epithelial cells 7 -8 . Infection with cytotoxic strains has been positively associated with peptic ulceration 9 and more severe degrees of gastric inflammation have been linked with infection with strains possessing the vacA gene signal sequence type sla 10 . Purified VacA has been shown to induce gastric ulceration and epithelial erosions in mice 11 . H. pylori expresses a variety of enzymes, some of which may have a role in mucosal injury 12 thereby contributing to changes in mucosal permeability 4 and facilitating the generation of specific immune responses. The most notable is urease, which by producing ammonia not only protects the organism from gastric acid but may also have toxic effects on the epithelium 3 . Bacterial phospholipases may degrade the phospholipid components of the gastric mucosal barrier, and H. pylori alcohol dehydrogenase-mediated acetaldehyde production may also have toxic effects 12 .
Epithelial chemokine responses
Peptides belonging to the chemokine family are involved in the recruitment and activation of specific immune cells (Fig. la) . Different chemokines show marked target cell specificity with members of the C-X-C sub-family (e.g. IL-8, GRO-a) having specific chemotactic activity for neutrophils and members of the C-C family (e.g. RANTES, MlP-la) having effects on monocytes and lymphocytes 13 . A variety of studies have shown that the gastric epithelium is an important source of chemokines 14 " 19 , which are released both in response to H. pylori 14 , and epithelial production of IL-8 may contribute towards the increased secretion observed from cultured whole antral biopsies 22 . Recently, transcription of other members of the C-X-C chemokine family, as well as those with specificity for monocytes and lymphocytes (RANTES, MTP-la) has been reported in H. pylori infected mucosa 23 *
24
. The epithelial chemokine response may be particularly important in the early stages of H. pylori-induced inflammation, with the epithelium acting as a crucial first line of defense against microbial infection
Non-specific immunity
The primary host defence mechanism to microbial attack usually involves a polymorph response. Although acute H. pylori infection in man has rarely been documented, limited histopathological studies suggest that there is indeed an initial strong neutrophilic response 25 . Persistence of an active neutrophil component in chronic infection 2 implies an important ongoing role for these cells in H. py/on-induced inflammation. In addition to the epithelial chemotactic cytokine response, diffusion of various bacterial products directly into the mucosa may result in neutrophil recruitment and activation (Fig. lb) .
In vitro, H. pylori is a potent source of factors capable of inducing neutrophil chemotaxis and activation. H. pylori water extract can induce adhesion and emigration of leukocytes from rat mesenteric venules 26 , and in vitro exposure of human polymorphs to components of H. pylori leads to changes in adhesion molecule expression, chemotaxis, degranulation and the generation of reactive oxygen metabolites 26 " 34 . A variety of bacterial products are implicated, including a 150 kDa H. pylori neutrophil activating protein (HP-NAP) 34 . Mononuclear phagocytes play a central role in early immune responses to bacteria, serving as an important source of pro-inflammatory mediators and as antigen-presenting cells involved in the initiation of specific immunity. H. pylori-derived soluble proteins (including a lipopolysaccharide-free extract) will activate peripheral blood monocytes in vitro, leading to increased expression of HLA-DR and interleukin-2 receptors, production of the inflammatory cytokines interleukin-1 and tumour necrosis factor-a (peptide and mRNA), and secretion of superoxide anion 35 . Recent studies suggest the LPSindependent cytokine production may be mediated by the urease enzyme 36 . In vitro culture of endoscopic antral biopsies has shown increased secretion of tumour necrosis factor-a, interleukin-6 and interleukin-1 P in H. pylori infected subjects 3738 , all three peptides being predominantly macrophage-derived cytokines with a wide range of proinflammatory actions involved in leukocyte recruitment and activation.
As well as cytokines, the cells of the natural immune system are involved in the secretion of bio-active lipids which further contribute to recruitment and activation of phagocytic cells. Leukotriene B 4 (LT-B 4 ) induces neutrophil adhesion, chemotaxis, and degranulation in vitro, and is found in increased amounts in the mucosa of H. pylori infected subjects, particularly where there is active gastritis 39 . Data are at present conflicting as to whether mucosal prostaglandin levels are altered in H. pylori infection 40 " 42 .
Specific immunity
The presence of T-lymphocytes and plasma cells in the inflammatory infiltrate in H. pylori chronic gastritis suggests antigen-specific cellular and humoral immune mechanisms are important (Fig. lc) . The finding of increased numbers of CD45RO + (antigen-committed) memory-type 43 and CD25 positive 44 T cells in the mucosa further supports this view. H. pylori infection results in the development of organised gastric lymphoid follicles which gradually decline in number after eradication of the organism, suggesting that specific H. pylori antigenic stimulation is required 45 ' 46 . Localisation of accessory cells (macrophages and follicular dendritis cells) in this acquired gastric lymphoid tissue resembles patterns in lymphoid tissue elsewhere in the gastrointestinal tract suggesting these cells facilitate antigen delivery from the gastric lumen 46 . However, the mechanism of initial antigen uptake from the gastric luminal surface in vivo is unclear, but could involve passive absorption of soluble products, direct epithelial endocytosis of shed bacterial antigens or the passage of antigen through disrupted epithelial tight junctions . T-helper cells are classified into 2 main types, depending on characteristic cytokine profiles (originally described in mice). Thl lymphocytes secrete IL-2 and interferon-y and mediate cellular immune responses, whereas Th2 cells produce IL-4, IL-5 and IL-10 which help in B-cell activation and antibody production including mucosal IgA responses 49 . Most antigens probably induce a mixture of responses but, over time, some chronic infections are characterised by a response that is either Thl or Th2 in nature. Cytokines produced early in infection are likely to polarise the specific T cell response 50 . H. pylori has been reported to induce IFN-y production by peripheral lymphocytes 51 , increase IFN-y producing cells (but not IL-4) in the gastric mucosa 52 , and increase mucosal mRNA expression of EFN-y and IL-12 48 which all strongly suggest a Thl response predominates 48 . The majority of H. pylori reactive T-cell clones generated from antral biopsies of infected patients exhibit a Thl cytokine profile on stimulation by H. pylori antigens 48 . This Thlpredominant lymphocyte response, favouring cell-mediated immunity, may not promote the elimination of H. pylori (as the bacterium is noninvasive), and may lead to cytotoxic damage of the epithelium 1 . Although a Thl response predominates in H. pylori infection, there is little doubt that humoral immunity also plays a role. Gastric H. pylori specific T cell clones express antigen-dependent helper function for B cell proliferation and immunoglobulin secretion 48 . H. py/on'-specific immunoglobulins A and M (IgA and IgM) antibodies are detectable by enzyme-linked immunoassay in gastric juice in about one-third of subjects with H. pylori gastritis 53 , and short-term biopsy cultures have subsequently confirmed local production of H. pylori specific IgG and IgA 54 . Coating of the bacteria lining the epithelium by antibodies 55 and activated complement components 56 has been demonstrated using immunohistochemistry. Hence, the plasma cell infiltrate seen in H. pylori gastritis appears to represent a local humoral response to the organism. Mucosal IgA may serve to inhibit antigen uptake, block bacterial adherence or neutralise toxins 157 . IgA does not activate complement efficiently, though recent work suggests that complement activation may be important in H. pylori gastritis 56 perhaps mediated through mucosal immunoglobulins of the IgG class.
Anti-inflammatory activity
Whilst a wide range of pro-inflammatory mediators have been implicated in H. pylori-induced inflammation, much less is known about the natural antagonists of these cytokines. The balance between pro-inflammatory and immunosuppressive cytokines is likely to be a critical determinant of the severity of H. pylori-associated inflammation. One explanation for the persistence of chronic H. pylori infection (despite apparent activation of cellular and humoral immunity) is immune down-regulation. In vitro studies have suggested that H. pylori may possess some immunosuppressive actions. H. pylori extracts have been shown to inhibit mitogen-induced proliferation of peripheral blood mononuclear cells 58 and a whole inactivated H. pylori preparation induced lower proliferative responses in blood mononuclear cells from H. pylori-intected subjects than from uninfected patients 51 . Increased levels of IL-10 (both secreted protein and mRNA) have recently been reported in H. pylori-infected mucosa, with levels of IL-10 increasing with the severity of gastritis 59 " 61 . IL-10 is a potent inhibitor of both phagocyte and lymphocyte responses and is produced by a variety of human cells, notably mononuclear phagocytes.
IgA antibodies specific for the cytokine IL-8 are produced by cultured antral biopsies in infected patients 22 , and IgA:IL-8 immune complexes have been reported in gastric juice 62 , though it is presently unclear whether such anti-cytokine antibodies have immunoregulatory functions in H. pylori infection.
Strain variation in the inflammatory response
Although H. pylori infection appears to be invariably associated with long-term chronic gastritis, the severity of mucosal inflammation induced by the organism and the occurrence of clinically significant gastroduodenal lesions is highly variable, with only a minority of infected subjects developing serious disease, pifferences in the pathogenicity of infecting H. pylori strains may be one mechanism involved in this diversity of clinical outcome.
Molecular analysis has allowed the identification of two groups of H. pylori based on the presence or absence of the cagA gene (cytotoxinassociated gene A), which encodes an immunodominant 120-140 kDa protein 63 ' 64 , and associated genes in the cag pathogenicity island (cagFAl) 65 ' 66 . Systemic and mucosal humoral recognition of the CagA protein has been linked to peptic ulceration in some studies 67 " 69 , and mucosal IgA recognition of CagA has been associated with the degree of mucosal neutrophil infiltration ('activity') and the extent of surface epithelial degeneration 67 . Studies of the relationship between systemic humoral recognition of CagA and gastritis activity have not consistently found an association, though this may reflect differences between mucosal and systemic humoral responses or differences in ethnicity of study populations 70 . 
Autoimmunity
Molecular mimicry of host structures by bacteria can lead to the generation of specific immunity directed against self-antigens and subsequent immunologically mediated host injury. Sequence homology between a number of H. pylori polypeptides and those of the host have been demonstrated, including gastric H7K + -ATPase 76 . The finding that monoclonal antibodies directed against H. pylori could recognise an epitope on the gastric epithelium of mice and humans, and that administration of these antibodies produced gastritis in mice, led to speculation about a possible role for autoimmunity in H. pyloriassociated mucosal inflammation 77 . Autoreactive IgG antibodies present in patient's sera will bind to gastric corpus mucosa, and pre-absorption of these sera with H. pylori cells abolishes the cross reaction 78 . Recent interest has focused on the finding that H. pylori lipopolysaccharide expresses Lewis x (Le*) and Lewis y (Le y ) human blood group antigens 7980 (which are found on various host cells, including human gastric mucosa). Interestingly, Le* and Le y expression is more frequently observed in cag* strains 81 . Humans infected with H. pylori produce antiLe x antibodies 80 , and immunohistochemistry has shown that H. pylori induced anti-Lewis monoclonal antibodies react strongly with human gastric mucosa 80 . 76 . The resolution of gastritis after bacterial eradication suggests autoimmune responses, whether against LPS determinants or other cross-reacting antigens such as heat shock proteins 76 have no long term effect on mucosal integrity.
Conclusion
The immune response to H. pylori is co-ordinated by a complex network of inflammatory mediators, including chemokines and proinflammatory and immunosuppressive peptides, which are derived from the gastric epithelium and underlying mucosal immune cells. Strainspecific variations in the magnitude and characteristics of these cytokine responses are an important factor in determining the degree of chronic gastric inflammation, and may contribute to the broad spectrum of clinical manifestations observed.
